Author

LESLIE CARTER

OpenAlex ID: A5081117451

269-OR: Glucagon Antagonism Improves Insulin Sensitivity and Increases Lean Body Mass in Patients with Type 1 Diabetes—A Twelve-Week Double-Blind, Randomized, Placebo-Controlled Trial

2025 · SCHAFER C. BOEDER, ROBERT L. THOMAS, et al. · Diabetes · 1

1578-P: Circulating Mitochondrial DNA Provides a Novel Biomarker for Hyperinsulinemia and Disease Severity in Type 2 Diabetes

2025 · ROBERT L. THOMAS__III, JESSE D. GARCIA, et al. · Diabetes

267-OR: ADA Presidents' Select Abstract: Combining an SGLT Inhibitor with a Glucagon Receptor Agonist (GRA) in Subjects with Type 1 Diabetes—A Randomized Clinical Trial

2023 · SCHAFER C. BOEDER, MELISSA J. LE ROUX, et al. · Diabetes

322-OR: SGLT2 Inhibition Has No Effect on the Counterregulatory Response to Hypoglycemia in Subjects with Type 1 Diabetes (T1D)

2021 · SCHAFER C. BOEDER, DANIEL G. INES, et al. · Diabetes

128-LB: Effects of Glucagon Receptor Antagonism (GRA) on Ketone Body Formation during Insulinopenia in Type 1 Diabetes (T1D)

2020 · SCHAFER C. BOEDER, DANIEL G. INES, et al. · Diabetes

Works count: 5

Citation count: 1

H-index: 1

I10-index: